CLSD(Delisted)
Clearside Biomedical·NASDAQ
--
--(--)
Clearside Biomedical (CLSD) Company Profile
Clearside Biomedical, Inc.
A company developing opthalmic therapeutic products
900 North Point Parkway, Suite 200, Alpharetta, GA 30005
--
Clearside Biomedical, Inc., was incorporated in Delaware on May 26, 2011. The company is a late-stage clinical biopharmaceutical company that develops first-in drug therapies to treat blinding diseases of the eye. The company's current product candidates focus on addressing diseases affecting the retina and choroid, especially macular edema, and are injected into the suprachoroidal space using its proprietary SCS microinjector.
